PesoRama Announces $25 Million Bought Deal Public Offering
News related to:PesoRama Inc · 3 min read
PesoRama Inc., a Canadian company operating dollar stores in Mexico under the JOi DOLLAR PLUS brand, has announced a significant fundraising effort through a bought deal public offering. The company plans to raise approximately $25 million by issuing 41,667,000 common shares from its treasury at a price of $0.60 per share. This offering, which includes an over-allotment option for up to an additional 6,250,050 common shares, is expected to generate an additional $3,750,030 in gross proceeds, if fully exercised.
The prospectus supplement, dated October 7, 2026, has been filed with the securities commissions in each of the provinces of Canada, excluding Quebec. This document, along with the company’s short form base shelf prospectus dated September 23, 2026, will be accessible on SEDAR+ at www.sedarplus.ca.
The offering is expected to close on or about October 14, 2026, subject to regulatory approval, including that of the TSX Venture Exchange. PesoRama Inc. operates as a Mexican value retailer, currently managing a chain of stores under the JOi DOLLAR PLUS brand. The company aims to expand its presence, targeting a network of 500+ locations across Mexico. This fundraising initiative is part of the company’s broader strategy to strengthen its market position and support its growth plans.
The legal framework for this offering is in compliance with the relevant securities laws of Canada and the United States. The U.S. Securities Act of 1933, as amended, allows for the sale of the common shares in the United States on a private placement basis, provided that no registration is required. PesoRama Inc. has engaged CP LLP as its legal counsel, with Dentons Canada LLP acting as counsel for the underwriters in connection with the offering.
The Base Shelf Prospectus and the Prospectus Supplement are accessible on the Company's profile at SEDAR+ at www.sedarplus.ca. Prospective investors should read the Base Shelf Prospectus and the Prospectus Supplement in their entirety before making an investment decision.
This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.
Cautionary Note This press release contains "forward-looking information" within the meaning of applicable securities laws, including, among other things, statements regarding the completion of the Offering, the Closing Date and the receipt of all necessary regulatory approvals, including that of the TSXV. While the Company believes that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements, including due to changes in consumer behaviour, general economic factors, the ability of the Company to execute its strategies, the availability of capital and the risk factors which are discussed in greater detail in the "Risk Factors" section of the Company's annual information form for the year ended January 31, 2026 and filed under the Company's profile on www.sedarplus.ca. The statements in this press release are made as of the date of this release. PesoRama undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of PesoRama, its securities, or its financial or operating results (as applicable).